120 related articles for article (PubMed ID: 17143196)
1. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes.
van de Garde EM; Souverein PC; Hak E; Deneer VH; van den Bosch JM; Leufkens HG
J Hypertens; 2007 Jan; 25(1):235-9. PubMed ID: 17143196
[TBL] [Abstract][Full Text] [Related]
2. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
[TBL] [Abstract][Full Text] [Related]
3. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population.
van de Garde EM; Souverein PC; van den Bosch JM; Deneer VH; Leufkens HG
Eur Respir J; 2006 Jun; 27(6):1217-22. PubMed ID: 16455828
[TBL] [Abstract][Full Text] [Related]
5. Statin treatment and reduced risk of pneumonia in patients with diabetes.
van de Garde EM; Hak E; Souverein PC; Hoes AW; van den Bosch JM; Leufkens HG
Thorax; 2006 Nov; 61(11):957-61. PubMed ID: 16809409
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.
Liu CL; Shau WY; Wu CS; Lai MS
J Hypertens; 2012 Nov; 30(11):2223-9. PubMed ID: 22929610
[TBL] [Abstract][Full Text] [Related]
7. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
8. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
Etminan M; Zhang B; Fitzgerald M; Brophy JM
Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.
de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737
[TBL] [Abstract][Full Text] [Related]
10. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1173-82. PubMed ID: 22949094
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes.
Faillie JL; Filion KB; Patenaude V; Ernst P; Azoulay L
Diabetes Obes Metab; 2015 Apr; 17(4):379-85. PubMed ID: 25581902
[TBL] [Abstract][Full Text] [Related]
13. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients.
Okaishi K; Morimoto S; Fukuo K; Niinobu T; Hata S; Onishi T; Ogihara T
Am J Hypertens; 1999 Aug; 12(8 Pt 1):778-83. PubMed ID: 10480470
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study.
Sjöberg T; García Rodríguez LA; Lindblad M
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1160-1166.e1. PubMed ID: 17916544
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Coleman CI; Makanji S; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
[TBL] [Abstract][Full Text] [Related]
18. Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: a case-control study.
Marciniak C; Korutz AW; Lin E; Roth E; Welty L; Lovell L
Am J Phys Med Rehabil; 2009 Jan; 88(1):30-8. PubMed ID: 19096289
[TBL] [Abstract][Full Text] [Related]
19. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
Mathieson L; Severn A; Guthrie B
Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
[TBL] [Abstract][Full Text] [Related]
20. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
Maahs DM; Snell-Bergeon JK; Kinney GL; Wadwa RP; Garg S; Ogden LG; Rewers M
J Diabetes Complications; 2007; 21(5):273-9. PubMed ID: 17825750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]